Baird Medical Investment (BDMD) Competitors $2.58 -0.16 (-5.84%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BDMD vs. RBOT, ECOR, APT, ICCM, SPAI, ZYXI, QTI, EDAP, DXR, and WOKShould you be buying Baird Medical Investment stock or one of its competitors? The main competitors of Baird Medical Investment include Vicarious Surgical (RBOT), electroCore (ECOR), Alpha Pro Tech (APT), IceCure Medical (ICCM), Safe Pro Group (SPAI), Zynex (ZYXI), QT Imaging (QTI), Edap Tms (EDAP), Daxor (DXR), and WORK Medical Technology Group (WOK). These companies are all part of the "medical equipment" industry. Baird Medical Investment vs. Its Competitors Vicarious Surgical electroCore Alpha Pro Tech IceCure Medical Safe Pro Group Zynex QT Imaging Edap Tms Daxor WORK Medical Technology Group Vicarious Surgical (NYSE:RBOT) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations. Do analysts recommend RBOT or BDMD? Vicarious Surgical presently has a consensus target price of $7.00, indicating a potential downside of 6.24%. Given Vicarious Surgical's stronger consensus rating and higher possible upside, research analysts clearly believe Vicarious Surgical is more favorable than Baird Medical Investment.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vicarious Surgical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Baird Medical Investment 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor RBOT or BDMD? In the previous week, Vicarious Surgical had 14 more articles in the media than Baird Medical Investment. MarketBeat recorded 15 mentions for Vicarious Surgical and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 1.88 beat Vicarious Surgical's score of 0.41 indicating that Baird Medical Investment is being referred to more favorably in the news media. Company Overall Sentiment Vicarious Surgical Neutral Baird Medical Investment Very Positive Is RBOT or BDMD more profitable? Baird Medical Investment's return on equity of 0.00% beat Vicarious Surgical's return on equity.Company Net Margins Return on Equity Return on Assets Vicarious SurgicalN/A -148.14% -98.07% Baird Medical Investment N/A N/A N/A Do insiders & institutionals have more ownership in RBOT or BDMD? 47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are held by institutional investors. 12.0% of Vicarious Surgical shares are held by company insiders. Comparatively, 78.9% of Baird Medical Investment shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has higher earnings & valuation, RBOT or BDMD? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVicarious SurgicalN/AN/A-$63.22M-$10.09-0.74Baird Medical InvestmentN/AN/AN/AN/AN/A Which has more volatility and risk, RBOT or BDMD? Vicarious Surgical has a beta of 1.41, meaning that its stock price is 41% more volatile than the S&P 500. Comparatively, Baird Medical Investment has a beta of -1, meaning that its stock price is 200% less volatile than the S&P 500. SummaryVicarious Surgical beats Baird Medical Investment on 5 of the 9 factors compared between the two stocks. Get Baird Medical Investment News Delivered to You Automatically Sign up to receive the latest news and ratings for BDMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BDMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BDMD vs. The Competition Export to ExcelMetricBaird Medical InvestmentMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.04M$7.07B$5.62B$9.84BDividend YieldN/A1.30%4.61%4.07%P/E RatioN/A25.4830.2925.74Price / SalesN/A73.48463.41115.83Price / CashN/A21.9738.2159.48Price / BookN/A5.388.826.15Net IncomeN/A$176.29M$3.25B$265.06M7 Day Performance21.13%3.76%4.05%2.80%1 Month Performance-22.29%-0.66%4.32%1.68%1 Year PerformanceN/A12.98%36.25%29.59% Baird Medical Investment Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BDMDBaird Medical InvestmentN/A$2.58-5.8%N/AN/A$18.04MN/A0.00N/APositive NewsGap UpHigh Trading VolumeRBOTVicarious Surgical0.8054 of 5 stars$9.01+1.6%$8.50-5.7%+52.0%$53.43MN/A-0.86210Trending NewsEarnings ReportAnalyst ForecastECORelectroCore2.6546 of 5 stars$7.15-1.4%$25.50+256.6%-14.0%$53.41M$25.18M-4.5850Analyst RevisionAPTAlpha Pro Tech1.2564 of 5 stars$4.86-0.2%N/A-14.7%$52.80M$58.18M13.14120Short Interest ↑ICCMIceCure Medical2.2906 of 5 stars$0.89-2.9%$2.50+180.0%+36.8%$52.30M$3.27M-3.1860News CoverageEarnings ReportAnalyst ForecastShort Interest ↑Gap DownSPAISafe Pro Group0.8806 of 5 stars$3.33-1.0%$8.00+140.5%N/A$49.69M$2.05M-4.0411Earnings ReportHigh Trading VolumeZYXIZynex2.8475 of 5 stars$1.57-9.0%$4.90+212.1%-77.8%$47.57M$192.35M-1.67770Gap DownQTIQT ImagingN/A$1.75-7.9%N/A+314.6%$47.48M$4.00M0.00N/APositive NewsEDAPEdap Tms3.0673 of 5 stars$1.26-1.2%$8.50+577.3%-68.0%$46.92M$69.18M-2.02230News CoverageShort Interest ↓Gap UpDXRDaxor4.0656 of 5 stars$9.68+0.2%$25.00+158.3%+28.3%$46.85MN/A0.0037Short Interest ↓Gap UpWOKWORK Medical Technology GroupN/A$0.79+3.4%N/AN/A$44.89M$11.51M0.00226Positive NewsGap Up Related Companies and Tools Related Companies RBOT Competitors ECOR Competitors APT Competitors ICCM Competitors SPAI Competitors ZYXI Competitors QTI Competitors EDAP Competitors DXR Competitors WOK Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BDMD) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baird Medical Investment Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Baird Medical Investment With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access